CHRISTOPHER SEAN GROGAN, PhD, Scientist


We are not a marketplace for illicit drugs.
We do NOT promote practitioners.
We DO support the spirit of harm reduction through education and community!



We aim to educate those curious about psychedelics find current information. Medicine: https://www.hopkinspsychedelic.org
CORE BENEFITS IN PALLIATIVE SETTINGS
Sustained Outcomes: Single-dose interventions have shown to maintain antidepressant and anxiolytic effects for months, and in some cases, up to 4.5 years later.
- Existential Relief: Research from institutions like Johns Hopkins suggests psychedelics can significantly reduce the fear of death, often through “mystical-type” experiences that foster a sense of interconnectedness and peace.
- PTSD:Sustained Outcomes: Single-dose interventions have shown to maintain CHRONIC DEPRESSION: antidepressant and anxiolytic effects for months, in some cases up to 4.5 years.
- PAIN: Beyond emotional support, psilocybin is being studied for its potential to reduce chronic pain by interacting with serotonin receptors and lowering systemic inflammation.
